Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel GET zebrafish larvae model of invasive mycoses

Oct. 15, 2019

ALKBH proteins are potential therapeutic targets in HNSCC

Oct. 15, 2019

ReNeuron announces phase I/IIa data on hRPC stem cell therapy in retinitis pigmentosa

Oct. 14, 2019

[68Ga]FAPI-04 imaging evaluated in studies in cancer patients

Oct. 14, 2019

Kodiak reports phase Ib data on KSI-301 in wet AMD, DME and RVO

Oct. 14, 2019

Auris reports phase Ib interim data on AM-201 for antipsychotic-induced weight gain and somnolence

Oct. 14, 2019

Eyevensys provides initial data from phase I/II study of EYS-606 for noninfectious uveitis

Oct. 14, 2019

RegenxBio presents phase I/IIa interim data on RGX-314 in wet AMD

Oct. 14, 2019

FDA approves Reyvow for acute treatment of migraine

Oct. 14, 2019

RedHill reports full data from phase III MAP US study of RHB-104 in Crohn's disease

Oct. 14, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...